Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • mdwhittier mdwhittier Mar 21, 2013 11:45 PM Flag

    ACAD OWNS WORLDWIDE RIGHTS TO PIMAVANSERIN

    And, will likely become dominant over the other current leading anti-psychcotic meds (Abilify), quetiapine (Seroquel), and olanzapine (Zyprexa), due to their negative side-effects. Once approved, Rx's will eventually break out beyond Parkinson's psychosis symptoms. Still a ways to go until approval but definitely good for the long haul unless some currently unknown negative side effect emerges with sustained use, but the Phase III should have teased that out already. Be careful with setting your stops to tight; could be a rocky ride and you might get your shares sold out from underneath you.

    Sentiment: Strong Buy

 
ACAD
41.69+0.02(+0.05%)Jul 2 4:00 PMEDT